Emerging drugs for idiopathic thrombocytopenic purpura in adults

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.13, Iss.2, 2008-06, pp. : 237-254

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Investigational drugs in thrombotic thrombocytopenic purpura

By Noris Patrizia Balduini Carlo L

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 8, 2011-08 ,pp. : 1087-1098

Informa Healthcare

Access to resources Recommend Favorite

BCG vaccine: Idiopathic thrombocytopenic purpura in an infant: case report

Reactions Weekly, Vol. 1, Iss. 1189, 2008-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Measles rubella vaccine conjugate: Idiopathic thrombocytopenic purpura in an infant: case report

Reactions Weekly, Vol. 1, Iss. 1178, 2007-01 ,pp. : 26-26

Adis International

Access to resources Recommend Favorite

Hepatitis B vaccine recombinant: Idiopathic thrombocytopenic purpura in a neonate: case report

Reactions Weekly, Vol. 1, Iss. 1234, 2009-01 ,pp. : 21-22

Adis International

Access to resources Recommend Favorite

Eltrombopag is an effective treatment for patients with chronic idiopathic thrombocytopenic purpura

Inpharma, Vol. 1, Iss. 1544, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite